Analysts expect over 2019 rising revenue Carl Zeiss Meditec

Tomorrow the German Carl Zeiss Meditec will report its past quarter results. For this year Carl Zeiss Meditec's revenue will be around 1,42 billion euros. This is according to the average of the analysts' estimates. This is rather significant more than 2018's revenue of 1,28 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2019

financial analysis

The analysts expect for 2019 a net profit of 164 million euros. According to most of the analysts the company will have a profit per share for this book year of 1,84 euros. With this the price/earnings-ratio is an extreme 51,03.

Per share the analysts expect a dividend of 0,63 cents per share. Thus the dividend yield equals 0,67 percent. The average dividend yield of the pharmaceutical companies is a limited -3 percent.

Most recent target prices around 80 euros

Independent Research, Kepler Capital Markets and Hauck & Aufhauser recently provided recommendations for the stock.

Based on the current number of shares Carl Zeiss Meditec's market capitalization equals 8,4 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite volatile. Since last August the stock is even 38 percent higher. This year the stock price moved between 60 and 101 euro.

At 13.07 the stock trades 0,53 percent higher at 93,9 euros.

Historical stock prices Carl Zeiss Meditec period 2007-2019

financial analysis carlzeissmeditec News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.